DiaMedica Announces Positive Results in Top-Line Data from the Phase II ReMEDy Acute Ischemic Stroke Study and Provides a Business Update and First Quarter 2020 Financial Results
Stock Information for DiaMedica Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.